World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 300 speakers, multiple streams and over 1200 attendees from pharma, biotech and Payers/HTA’s.
The 2023 edition will now take place over three days with expanded content on
RWE, HTA, Medical Devices, Affordability, Digital Health, Analytics
We will also be strengthening our core topic areas which include, Market Access and Pricing, Rare Diseases, HTA/Payer and Evidence by covering the latest trends in reimbursement, payment models, affordability, HEOR and many other developments within the industry.
We are proud to work with a number of solution providers regarding sponsorship for this year’s event including IQVIA, Eversana and Certara.
EPA is a world leading forum which gives you the opportunity to showcase your solutions and thought leadership to key stakeholders across pharma and biotech.